Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22

doi:10.3748/wjg.v23.i11.2002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7617)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-11) series, Tables (1-3) series.

Item

Count

PDF

429

WORD

221

HTML

4087

Figures (1-11)

222

Tables (1-3)

219

Sum=5178

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

978

Download

1461

Sum=2439

Mar 21, 2017 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Mar 21, 2017; 23(11): 2002-2011
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2002

Full Size Figure Download Figure

Figure 2 Effects of interleukin-22 on HSC-T6 cells proliferation. ^aP < 0.05 vs the control group; ^cP < 0.05 vs the model group. HSCs: Hepatic stellate cells; IL: Interleukin.

Citation: Ni YH, Huo LJ, Li TT. Antioxidant axis Nrf2-keap1-ARE in inhibition of alcoholic liver fibrosis by IL-22. World J Gastroenterol 2017; 23(11): 2002-2011
URL: https://www.wjgnet.com/1007-9327/full/v23/i11/2002.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i11.2002